Literature DB >> 10972292

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma.

T Sasaki1, J Irie-Sasaki, Y Horie, K Bachmaier, J E Fata, M Li, A Suzuki, D Bouchard, A Ho, M Redston, S Gallinger, R Khokha, T W Mak, P T Hawkins, L Stephens, S W Scherer, M Tsao, J M Penninger.   

Abstract

Phosphoinositide-3-OH kinases (PI(3)Ks) constitute a family of evolutionarily conserved lipid kinases that regulate a vast array of fundamental cellular responses, including proliferation, transformation, differentiation and protection from apoptosis. PI(3)K-mediated activation of the cell survival kinase PKB/Akt, and negative regulation of PI(3)K signalling by the tumour suppressor PTEN (refs 3, 4) are key regulatory events in tumorigenesis. Thus, a model has arisen that PI(3)Ks promote development of cancers. Here we report that genetic inactivation of the p110gamma catalytic subunit of PI(3)Kgamma (ref. 8) leads to development of invasive colorectal adenocarcinomas in mice. In humans, p110gamma protein expression is lost in primary colorectal adenocarcinomas from patients and in colon cancer cell lines. Overexpression of wild-type or kinase-dead p110gamma in human colon cancer cells with mutations of the tumour suppressors APC and p53, or the oncogenes beta-catenin and Ki-ras, suppressed tumorigenesis. Thus, loss of p110gamma in mice leads to spontaneous, malignant epithelial tumours in the colorectum and p110gamma can block the growth of human colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972292     DOI: 10.1038/35022585

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation.

Authors:  Yutaka Kondo; Lanlan Shen; Pearlly S Yan; Tim Hui-Ming Huang; Jean-Pierre J Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

2.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

3.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  Targeting PI3K in neuroblastoma.

Authors:  Volker Spitzenberg; Christian König; Susanne Ulm; Romina Marone; Luise Röpke; Jörg P Müller; Michael Grün; Reinhard Bauer; Ignacio Rubio; Matthias Paul Wymann; Astrid Voigt; Reinhard Wetzker
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-12       Impact factor: 4.553

5.  Correlation between Mcl-1 and pAKT protein expression in colorectal cancer.

Authors:  Evita B Henderson-Jackson; James Helm; Masoumeh Ghayouri; Ardeshir Hakam; Aejaz Nasir; Marino Leon; Marilyn Bui; Timothy Yeatman; Domenico Coppola
Journal:  Int J Clin Exp Pathol       Date:  2010-10-12

6.  The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Authors:  Sabine M Ivison; Mohammed A S Khan; Nicholas R Graham; Leila A Shobab; Yu Yao; Arnawaz Kifayet; Laura M Sly; Theodore S Steiner
Journal:  Mediators Inflamm       Date:  2010-10-03       Impact factor: 4.711

7.  Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection.

Authors:  Christoph Schneider; Samuel P Nobs; Alex K Heer; Emilio Hirsch; Josef Penninger; Owen M Siggs; Manfred Kopf
Journal:  J Leukoc Biol       Date:  2016-07-28       Impact factor: 4.962

8.  Adenomatous polyposis coli regulates oligodendroglial development.

Authors:  Jordan Lang; Yoshiko Maeda; Peter Bannerman; Jie Xu; Makoto Horiuchi; David Pleasure; Fuzheng Guo
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

Review 9.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

10.  Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.

Authors:  Yan Xie; Peter W Abel; Joseph K Kirui; Caishu Deng; Poonam Sharma; Dennis W Wolff; Myron L Toews; Yaping Tu
Journal:  Biochem Pharmacol       Date:  2013-03-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.